Wells Fargo Starts Maze Therapeutics (MAZE) at Overweight
Tweet Send to a Friend
(Updated - December 4, 2025 5:27 AM EST)
Wells Fargo analyst Sadia Rahman initiates coverage on Maze Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells Fargo analyst Sadia Rahman initiates coverage on Maze Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
